KR20060000043A - 복재신경 포착에 의한 무릎 관절 통증 치료를 위한,보툴리눔 독소를 포함하는 제약 조성물 - Google Patents
복재신경 포착에 의한 무릎 관절 통증 치료를 위한,보툴리눔 독소를 포함하는 제약 조성물 Download PDFInfo
- Publication number
- KR20060000043A KR20060000043A KR1020040048889A KR20040048889A KR20060000043A KR 20060000043 A KR20060000043 A KR 20060000043A KR 1020040048889 A KR1020040048889 A KR 1020040048889A KR 20040048889 A KR20040048889 A KR 20040048889A KR 20060000043 A KR20060000043 A KR 20060000043A
- Authority
- KR
- South Korea
- Prior art keywords
- botulinum toxin
- pain
- pharmaceutical composition
- knee
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
대조군 | 보툴리늄 독소 타입 A 투여군 | p 값 | |
기준선 | 8.10 ±2.16 | 7.35 ±2.44 | NS |
1주 후 | 6.75 ±2.64 | 5.83 ±2.45 | NS |
3주 후 | 6.03 ±2.35 | 4.59 ±2.69 | < 0.05 |
대조군 | 보툴리늄 독소 타입 A 투여군 | p 값 | |
기준선 | 17.1 ±6.50 | 13.4 ±6.54 | NS |
1주 후 | 16.9 ±6.30 | 12.1 ±5.71 | < 0.05 |
3주 후 | 17.2 ±5.36 | 12.1 ±6.30 | < 0.05 |
Claims (5)
- 보툴리눔 독소 및 제약상 허용되는 담체를 포함하는, 무릎 내측 위의 피하에 주사되는, 복재신경 포착에 의한 무릎 관절 통증 치료를 위한 제약 조성물.
- 제1항에 있어서, 약 20 내지 200 LD50 유닛의 상기 보툴리눔 독소를 포함하는 제약 조성물.
- 제1항에 있어서, 상기 제약 조성물이 무릎 내측 위의 복재신경 지배 부위의 과민 수용체가 밀집되어 있는 피하근막에 주사되는 것인 제약 조성물.
- 제1항에 있어서, 상기 보툴리눔 독소가 보툴리눔 독소 타입 A인 제약 조성물.
- 제1항에 있어서, 무릎 관절 통증이 4주 이상 지속적으로 완화되는 것인 제약 조성물.
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040048889A KR100668570B1 (ko) | 2004-06-28 | 2004-06-28 | 복재신경 포착에 의한 무릎 관절 통증 치료를 위한,보툴리눔 독소를 포함하는 제약 조성물 |
ARP050102648A AR050673A1 (es) | 2004-06-28 | 2005-06-27 | Composicion farmaceutica compuesta por toxina botulinica para el tratamiento del dolor en la articulacion de la rodilla por compresion del nervio safeno |
ES05765839.5T ES2625128T3 (es) | 2004-06-28 | 2005-06-27 | Composición farmacéutica que comprende toxina botulínica para tratar el dolor articular de rodilla por atrapamiento del nervio safeno |
PT57658395T PT1771195T (pt) | 2004-06-28 | 2005-06-27 | Composição farmacêutica compreendendo toxina botulínica para tratar dor de articulação de joelho por compressão do nervo safeno |
US11/630,099 US20080199497A1 (en) | 2004-06-28 | 2005-06-27 | Pharmaceutical Composition Comprising Botulinum Toxin for Treating Knee Joint Pain by Saphenous Nerve Entrapment |
PCT/KR2005/002002 WO2006001676A1 (en) | 2004-06-28 | 2005-06-27 | Pharmaceutical composition comprising botulinum toxin for treating knee joint pain by saphenous nerve entrapment |
JP2007519119A JP4933429B2 (ja) | 2004-06-28 | 2005-06-27 | 伏在神経絞扼による膝関節痛の治療のための、ボツリヌス毒素を含む薬学組成物 |
DK05765839.5T DK1771195T3 (en) | 2004-06-28 | 2005-06-27 | PHARMACEUTICAL COMPOSITION COMPREHENSIVE BOTULINUM TOXIN FOR TREATMENT OF KNEE PAIN AS A CONSEQUENCE OF NERVUS SAPHENUS |
EP05765839.5A EP1771195B1 (en) | 2004-06-28 | 2005-06-27 | Pharmaceutical composition comprising botulinum toxin for treating knee joint pain by saphenous nerve entrapment |
PL05765839T PL1771195T3 (pl) | 2004-06-28 | 2005-06-27 | Kompozycja farmaceutyczna zawierająca toksynę botulinową do leczenia bólu stawu kolanowego powodowanego przez uwięźnięcie nerwu odpiszczelowego |
CA2571415A CA2571415C (en) | 2004-06-28 | 2005-06-27 | Pharmaceutical composition comprising botulinum toxin for treating knee joint pain by saphenous nerve entrapment |
HUE05765839A HUE033364T2 (en) | 2004-06-28 | 2005-06-27 | Pharmaceutical preparation containing botulinum toxin for treating knee pain due to pinching of nerve saphenus |
US12/506,622 US8337862B2 (en) | 2004-06-28 | 2009-07-21 | Method for treating knee joint pain caused by saphenous nerve entrapment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040048889A KR100668570B1 (ko) | 2004-06-28 | 2004-06-28 | 복재신경 포착에 의한 무릎 관절 통증 치료를 위한,보툴리눔 독소를 포함하는 제약 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20060000043A true KR20060000043A (ko) | 2006-01-06 |
KR100668570B1 KR100668570B1 (ko) | 2007-01-16 |
Family
ID=35782045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020040048889A KR100668570B1 (ko) | 2004-06-28 | 2004-06-28 | 복재신경 포착에 의한 무릎 관절 통증 치료를 위한,보툴리눔 독소를 포함하는 제약 조성물 |
Country Status (12)
Country | Link |
---|---|
US (2) | US20080199497A1 (ko) |
EP (1) | EP1771195B1 (ko) |
JP (1) | JP4933429B2 (ko) |
KR (1) | KR100668570B1 (ko) |
AR (1) | AR050673A1 (ko) |
CA (1) | CA2571415C (ko) |
DK (1) | DK1771195T3 (ko) |
ES (1) | ES2625128T3 (ko) |
HU (1) | HUE033364T2 (ko) |
PL (1) | PL1771195T3 (ko) |
PT (1) | PT1771195T (ko) |
WO (1) | WO2006001676A1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016002984A1 (ko) * | 2014-06-30 | 2016-01-07 | (주)메디톡스 | 보툴리눔 독소를 유효성분으로 포함하는 골관절염 치료용 약제학적 조성물 및 그를 이용한 골관절염 치료 방법 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8722060B2 (en) * | 2012-05-23 | 2014-05-13 | William J. Binder | Method of treating vertigo |
BR112014029585A2 (pt) | 2012-05-30 | 2017-07-25 | Harvard College | neurotoxina botulínica engendrada |
CN107548402B (zh) | 2015-03-26 | 2022-08-19 | 哈佛大学校长及研究员协会 | 工程改造的肉毒杆菌神经毒素 |
EP3504226A1 (en) | 2016-08-24 | 2019-07-03 | President and Fellows of Harvard College | Engineered botulinum neurotoxin |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6464986B1 (en) * | 2000-04-14 | 2002-10-15 | Allegan Sales, Inc. | Method for treating pain by peripheral administration of a neurotoxin |
US6623742B2 (en) * | 2001-09-17 | 2003-09-23 | Allergan, Inc. | Methods for treating fibromyalgia |
CA2369810C (en) * | 2002-01-30 | 2007-08-07 | 1474791 Ontario Limited | Method of treating pain |
AU2003212473A1 (en) * | 2002-03-01 | 2003-09-16 | Solstice Neurosciences, Inc. | Methods of treating nerve entrapment syndromes |
US7300412B2 (en) * | 2002-05-10 | 2007-11-27 | Hospital For Joint Diseases | Methods for therapeutic treatment of carpal tunnel syndrome |
US20040038874A1 (en) * | 2002-08-22 | 2004-02-26 | Osemwota Omoigui | Method of treatment of persistent pain |
US20060178354A1 (en) * | 2003-02-27 | 2006-08-10 | Lucas John M | Methods and compositions for the treatment of chronic pain using dhea and derivatives thereof |
-
2004
- 2004-06-28 KR KR1020040048889A patent/KR100668570B1/ko active IP Right Grant
-
2005
- 2005-06-27 EP EP05765839.5A patent/EP1771195B1/en not_active Not-in-force
- 2005-06-27 JP JP2007519119A patent/JP4933429B2/ja not_active Expired - Fee Related
- 2005-06-27 US US11/630,099 patent/US20080199497A1/en not_active Abandoned
- 2005-06-27 WO PCT/KR2005/002002 patent/WO2006001676A1/en active Application Filing
- 2005-06-27 AR ARP050102648A patent/AR050673A1/es not_active Application Discontinuation
- 2005-06-27 HU HUE05765839A patent/HUE033364T2/en unknown
- 2005-06-27 PT PT57658395T patent/PT1771195T/pt unknown
- 2005-06-27 CA CA2571415A patent/CA2571415C/en not_active Expired - Fee Related
- 2005-06-27 DK DK05765839.5T patent/DK1771195T3/en active
- 2005-06-27 PL PL05765839T patent/PL1771195T3/pl unknown
- 2005-06-27 ES ES05765839.5T patent/ES2625128T3/es active Active
-
2009
- 2009-07-21 US US12/506,622 patent/US8337862B2/en active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016002984A1 (ko) * | 2014-06-30 | 2016-01-07 | (주)메디톡스 | 보툴리눔 독소를 유효성분으로 포함하는 골관절염 치료용 약제학적 조성물 및 그를 이용한 골관절염 치료 방법 |
Also Published As
Publication number | Publication date |
---|---|
JP2008504364A (ja) | 2008-02-14 |
CA2571415C (en) | 2016-10-04 |
US20080199497A1 (en) | 2008-08-21 |
EP1771195B1 (en) | 2017-03-01 |
JP4933429B2 (ja) | 2012-05-16 |
PL1771195T3 (pl) | 2017-08-31 |
US8337862B2 (en) | 2012-12-25 |
WO2006001676A1 (en) | 2006-01-05 |
EP1771195A1 (en) | 2007-04-11 |
DK1771195T3 (en) | 2017-05-15 |
US20090317426A1 (en) | 2009-12-24 |
ES2625128T3 (es) | 2017-07-18 |
AR050673A1 (es) | 2006-11-15 |
KR100668570B1 (ko) | 2007-01-16 |
HUE033364T2 (en) | 2017-11-28 |
CA2571415A1 (en) | 2006-01-05 |
EP1771195A4 (en) | 2010-08-18 |
PT1771195T (pt) | 2017-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3238154B2 (ja) | 過度の発汗を軽減するためのボツリヌス毒素含有医薬組成物 | |
JP2005281317A (ja) | ジストニーを処置するためのa型ボツリヌス毒素に続くb型ボツリヌス毒素の使用 | |
US7910116B2 (en) | Use of a botulinum toxin to improve gastric emptying and/or to treat GERD | |
JP2003520822A (ja) | 糖尿病の治療方法 | |
WO2011011513A1 (en) | Inhibition of pathological bone formation | |
US8337862B2 (en) | Method for treating knee joint pain caused by saphenous nerve entrapment | |
JP2022548189A (ja) | ボツリヌス菌a型毒素複合体、製剤、およびその使用方法 | |
JP2008504364A5 (ja) | 伏在神経捕捉による膝関節痛の治療のための、ボツリヌス毒素を含む薬学組成物の使用 | |
RU2734159C1 (ru) | Фармацевтическая композиция для лечения болевого синдрома в стопе, включающая ботулинический токсин и гиалуроновую кислоту, и способ лечения болевого синдрома в стопе с ее использованием | |
AU2005215521A1 (en) | Treatment of abnormalities of the first metatarsophalangeal joint of the foot | |
US7820183B2 (en) | Botulinum toxin in treatment of clubfoot relapse | |
US20180280484A1 (en) | Treatment of raynaud's phenomenon using botulinum toxin type b | |
EP3658177B1 (en) | Tool for dosing botulinum neurotoxin | |
RU2788039C2 (ru) | Лечение спастичности нижних конечностей |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121226 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20131219 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20141231 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20151217 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20161220 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20171219 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20181226 Year of fee payment: 13 |